JPS6236321A - 抗腫瘍剤 - Google Patents

抗腫瘍剤

Info

Publication number
JPS6236321A
JPS6236321A JP60173106A JP17310685A JPS6236321A JP S6236321 A JPS6236321 A JP S6236321A JP 60173106 A JP60173106 A JP 60173106A JP 17310685 A JP17310685 A JP 17310685A JP S6236321 A JPS6236321 A JP S6236321A
Authority
JP
Japan
Prior art keywords
fluoro
deoxyuridine
methyl
antitumor agent
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60173106A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0413328B2 (fr
Inventor
Takeo Kawaguchi
川口　健夫
Minero Saneyoshi
実吉　峯郎
Masahiko Saito
斉藤　政彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP60173106A priority Critical patent/JPS6236321A/ja
Priority to DE8686303333T priority patent/DE3665260D1/de
Priority to EP86303333A priority patent/EP0202056B1/fr
Priority to US06/860,390 priority patent/US4916121A/en
Publication of JPS6236321A publication Critical patent/JPS6236321A/ja
Priority to MYPI87001280A priority patent/MY102464A/en
Publication of JPH0413328B2 publication Critical patent/JPH0413328B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP60173106A 1985-05-07 1985-08-08 抗腫瘍剤 Granted JPS6236321A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP60173106A JPS6236321A (ja) 1985-08-08 1985-08-08 抗腫瘍剤
DE8686303333T DE3665260D1 (en) 1985-05-07 1986-05-01 Antitumor agent
EP86303333A EP0202056B1 (fr) 1985-05-07 1986-05-01 Médicament anti-tumeur
US06/860,390 US4916121A (en) 1985-05-07 1986-05-07 Antitumor composition comprising pyrimidine type nucleic acid derivative and 1-[(2-hydroxyethoxy)methyl]uracil derivative
MYPI87001280A MY102464A (en) 1985-05-07 1987-08-11 Antitumor agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60173106A JPS6236321A (ja) 1985-08-08 1985-08-08 抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPS6236321A true JPS6236321A (ja) 1987-02-17
JPH0413328B2 JPH0413328B2 (fr) 1992-03-09

Family

ID=15954275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60173106A Granted JPS6236321A (ja) 1985-05-07 1985-08-08 抗腫瘍剤

Country Status (1)

Country Link
JP (1) JPS6236321A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59167904A (ja) * 1983-03-11 1984-09-21 日立電線株式会社 オーディオ機器配線用線材およびその製造方法
JPS63196519A (ja) * 1987-02-12 1988-08-15 Mitsui Toatsu Chem Inc 制ガン剤

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59167904A (ja) * 1983-03-11 1984-09-21 日立電線株式会社 オーディオ機器配線用線材およびその製造方法
JPH0129282B2 (fr) * 1983-03-11 1989-06-09 Hitachi Cable
JPS63196519A (ja) * 1987-02-12 1988-08-15 Mitsui Toatsu Chem Inc 制ガン剤

Also Published As

Publication number Publication date
JPH0413328B2 (fr) 1992-03-09

Similar Documents

Publication Publication Date Title
JP5357857B2 (ja) 抗ガン剤及びｄｎａ複製阻害剤
TWI503121B (zh) 用以治療癌症之組成物及方法
TW200927733A (en) Novel compounds and compositions and methods of use
HUE033727T2 (en) 2 ', 4'-difluoro-2'-methyl-substituted nucleoside derivatives as inhibitors of HCV RNA replication
BG61485B1 (bg) N горе 4-оксикарбонил заместени 5'-деокси-5-флуороцитидини
TW201124387A (en) Anti-tumor effect potentiator
JPH06507644A (ja) 抗癌剤としての２’−フルオロ−２−置換アデニニルアラビノシド
KR860001865B1 (ko) 2'-데옥시-5-치환 우리딘 유도체의 제조방법
CA2926909A1 (fr) Promedicament reciproque comportant des acides gras a chaine courte et de la zebularine ou de la 1'-cyano-cytarabine pour un traitement de cancer
WO2006115137A1 (fr) Dérivé de 2-aminobenzimidazole et utilisation de celui-ci à des fins médicales
TWI477508B (zh) 用以治療癌症之組成物及方法
JPS6344578A (ja) ピリミジン誘導体
JPS6236321A (ja) 抗腫瘍剤
JPWO2019160127A1 (ja) Ｄｎｍｔ阻害剤の用途
WO1996040680A1 (fr) Nouveaux analogues non classiques de folate inhibiteurs de la glycinamide ribonucleotide formyltransferase
KR0136869B1 (ko) 2'-메틸리덴피리미딘 뉴클레오시드 화합물, 그의 용도 및 제조방법
JPS62106017A (ja) 抗腫瘍剤
KR101414888B1 (ko) 1-(2'-시아노-2'-데옥시-β-Ｄ-아라비노푸라노실)시토신·1염산염의 신규 안정형 결정
EP0202056B1 (fr) Médicament anti-tumeur
JP2665527B2 (ja) ２’−デオキシ−２’−メチリデンピリミジンヌクレオチド化合物
JP2784941B2 (ja) ２’‐メチリデンピリミジンヌクレオシド化合物およびその医薬用途
WO2004080453A1 (fr) Agent anti-virus de l'hepatite c et agent anti-vih
JPS61254526A (ja) 経口投与用抗腫瘍剤
JPH0340038B2 (fr)
JP2512735B2 (ja) フルオロメチルチオリボ−ス誘導体及び腫瘍処置剤